Equities

Shandong Weigao Orthopaedic Device Co Ltd

688161:SHH

Shandong Weigao Orthopaedic Device Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)29.44
  • Today's Change-1.04 / -3.41%
  • Shares traded1.15m
  • 1 Year change-29.82%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Shandong Weigao Orthopaedic Device Co Ltd's revenues fell -30.55% from 1.85bn to 1.28bn. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from 544.21m to 112.32m, a -79.36% decrease.
Gross margin62.40%
Net profit margin12.43%
Operating margin14.72%
Return on assets3.14%
Return on equity3.94%
Return on investment3.95%
More ▼

Cash flow in CNYView more

In 2023, cash reserves at Shandong Weigao Orthopaedic Device Co Ltd fell by 886.31m. However, the company earned 119.44m from its operations for a Cash Flow Margin of 9.31%. In addition the company used 81.57m on investing activities and also paid 924.36m in financing cash flows.
Cash flow per share--
Price/Cash flow per share--
Book value per share9.78
Tangible book value per share9.44
More ▼

Balance sheet in CNYView more

Shandong Weigao Orthopaedic Device Co Ltd has little financial risk as the capital structure does not rely on leverage.
Current ratio4.38
Quick ratio3.62
Total debt/total equity0.0097
Total debt/total capital0.0096
More ▼

Growth rates in CNY

Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -70.61% and -79.42%, respectively. Additionally, five year annualized earnings per share growth ranks below the industry average relative to its peers.
Div yield(5 year avg)--
Div growth rate (5 year)--
Payout ratio (TTM)49.04%
EPS growth(5 years)-19.16
EPS (TTM) vs
TTM 1 year ago
-31.08
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.